SCHEMBL6120237

SCHEMBL6120237

Nc1cccc2c1[N]C(=O)N2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.33
ALDH1A1 P00352 2/20 0.33
AURKA O14965 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
TDP1 Q9NUW8 4/20 0.32
RECQL P46063 2/20 0.32
RPS6KA3 P51812 2/20 0.32
JAK2 O60674 1/20 0.32
MELK Q14680 1/20 0.32
STK24 Q9Y6E0 1/20 0.32
CD44 P16070 1/20 0.31
CYP3A4 P08684 3/20 0.31
TSHR P16473 2/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
DAPK3 O43293 1/20 0.31
PRKD3 O94806 1/20 0.31
MAP4K4 O95819 1/20 0.31
PAK4 O96013 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6230711 0.76 MEN1 (0.37) PARP1ALDH1A1AURKAAURKBTDP1
SCHEMBL4752983 0.76 PARP1 (0.37) PARP1
SCHEMBL6587215 0.76 PLAUR (0.31)
SCHEMBL4750499 0.76 CES1 (0.44) PARP1AURKARPS6KA3JAK2DAPK3
SCHEMBL4752467 0.72 CES1 (0.41) PARP1ALDH1A1TDP1HPGDHSD17B10
SCHEMBL5132320 0.72 TDP1 (0.44) PARP1ALDH1A1TDP1RECQLCYP3A4
SCHEMBL3741907 0.68
SCHEMBL20505096 0.66 MAPT (0.44) ALDH1A1HSD17B10PDGFRALTKGSK3B
SCHEMBL20723 0.66 MAPT (0.44) ALDH1A1HSD17B10PDGFRALTKGSK3B
SCHEMBL1270125 0.64 CES1 (0.48) PARP1AURKAAURKBINCENPTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2771334-A1 DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES Galderma Research & Development (FR) 2014-09-03 EP disclosed
WO-2013061005-A1 DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-05-02 WO disclosed
WO-2012068211-A1 TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-05-24 WO disclosed